# abrdn Palladium ETF Trust: financial statements, quarterly

PALL · NYSE · CIK 1459862 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pall.md) · [Financials](/companies/pall/financials.md) · [Filings](/companies/pall/filings.md) · [Insiders](/companies/pall/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pall/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [6.1](/filings/0001999371-24-014545.md) | [(26.5) d](/filings/0001999371-26-004972.md) | [(21.1)](/filings/0001999371-25-005702.md) | [(11.2)](/filings/0001999371-25-010848.md) | [9.9](/filings/0001999371-25-017266.md) | [(45.2) d](/filings/0001999371-26-004972.md) | [30.0](/filings/0001999371-26-010356.md) | [61.3](/filings/0001999371-26-017413.md) | [47.3](/filings/0001999371-25-017266.md) | [183 d](/filings/0001999371-26-004972.md) | [(77.2)](/filings/0001999371-26-010356.md) | [(125)](/filings/0001999371-26-017413.md) |
| Basic EPS | $ per share | [3.10](/filings/0001999371-24-014545.md) | not reported | [(9.02)](/filings/0001999371-25-005702.md) | [(3.81)](/filings/0001999371-25-010848.md) | [3.13](/filings/0001999371-25-017266.md) | not reported | [7.58](/filings/0001999371-26-010356.md) | [2.92](/filings/0001999371-26-017413.md) | [9.30](/filings/0001999371-25-017266.md) | not reported | [(10.73)](/filings/0001999371-26-010356.md) | [(4.22)](/filings/0001999371-26-017413.md) |

- Gross profit: not reported
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [232](/filings/0001839882-23-030159.md) | [219](/filings/0001839882-25-012446.md) | [224](/filings/0001999371-24-005860.md) | [284](/filings/0001999371-24-009835.md) | [273](/filings/0001999371-24-014545.md) | [354](/filings/0001999371-26-004972.md) | [369](/filings/0001999371-25-005702.md) | [516](/filings/0001999371-25-010848.md) | [622](/filings/0001999371-25-017266.md) | [1,036](/filings/0001999371-26-017413.md) | [790](/filings/0001999371-26-010356.md) | [598](/filings/0001999371-26-017413.md) |
| Total liabilities | $m | [0.1](/filings/0001839882-23-030159.md) | [0.1](/filings/0001839882-25-012446.md) | [0.1](/filings/0001999371-24-005860.md) | [0.1](/filings/0001999371-24-009835.md) | [0.1](/filings/0001999371-24-014545.md) | [0.2](/filings/0001999371-26-004972.md) | [0.2](/filings/0001999371-25-005702.md) | [0.2](/filings/0001999371-25-010848.md) | [0.3](/filings/0001999371-25-017266.md) | [0.5](/filings/0001999371-26-017413.md) | [0.4](/filings/0001999371-26-010356.md) | [6.9](/filings/0001999371-26-017413.md) |
| Shareholders' equity | $m | [231](/filings/0001999371-24-014545.md) | [219](/filings/0001999371-26-004972.md) | [224](/filings/0001999371-25-010848.md) | [284](/filings/0001999371-25-017266.md) | [273](/filings/0001999371-25-017266.md) | [354](/filings/0001999371-26-017413.md) | [369](/filings/0001999371-26-017413.md) | [515](/filings/0001999371-26-017413.md) | [622](/filings/0001999371-25-017266.md) | [1,035](/filings/0001999371-26-017413.md) | [790](/filings/0001999371-26-017413.md) | [591](/filings/0001999371-26-017413.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q4 FY2011 (2011-12-31) | Q1 FY2012 (2012-03-31) | Q2 FY2012 (2012-06-30) | Q3 FY2012 (2012-09-30) | Q4 FY2012 (2012-12-31) | Q1 FY2013 (2013-03-31) | Q2 FY2013 (2013-06-30) | Q3 FY2013 (2013-09-30) | Q4 FY2013 (2013-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0000930413-12-002977.md) | [0.0](/filings/0000930413-12-004465.md) | [0.0](/filings/0001459862-12-000003.md) | [0.0 d](/filings/0001459862-14-000004.md) | [0.0](/filings/0001459862-13-000004.md) | [0.0](/filings/0001459862-13-000013.md) | [0.0](/filings/0001459862-12-000003.md) | [0.0 d](/filings/0001459862-15-000002.md) | [0.0](/filings/0001562762-14-000133.md) | [0.0](/filings/0001459862-14-000016.md) | [0.0](/filings/0001459862-14-000018.md) | [0.0 d](/filings/0001459862-16-000015.md) |
| Share repurchases | $m | [(153)](/filings/0000930413-12-002977.md) | [(77.5)](/filings/0000930413-12-004465.md) | [182](/filings/0001459862-12-000003.md) | [108 d](/filings/0001459862-14-000004.md) | [0.0](/filings/0000930413-12-002977.md) | [17.4](/filings/0001459862-13-000013.md) | [28.6](/filings/0001459862-13-000016.md) | [52.9 d](/filings/0001459862-15-000002.md) | [6.8](/filings/0001562762-14-000133.md) | [49.4](/filings/0001459862-14-000016.md) | [28.8](/filings/0001459862-14-000018.md) | [49.0 d](/filings/0001459862-16-000015.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 27,062,500 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001999371-26-017413.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.